Strides Shasun receives tentative nod from USFDA for HIV drug Efavirenz

Posted on:27 May 2016 14:36:06
Strides Shasun receives tentative nod from USFDA for HIV drug Efavirenz
27 May 2016 Current Affairs: Strides Shasun has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for Efavirenz tablets USP, 600 mg on 26 May 2016.

The final approval will be received after patent expiry in August 2018. The company will manufacture the product at its oral dosage facility in Bengaluru.

About Efavirenz : Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI).It is used as part of Highly Active Antiretroviral Therapy (HAART) for the treatment of a Human Immunodeficiency Virus (HIV) type 1. It is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk. It was discovered at Merck Research Laboratories.It is on the WHO Model List of Essential Medicines, the most important medication needed in a basic health system.

Strides Shasun : Strides Arcolab is an Indian pharmaceutical company, headquartered at Bangalore in southern India.The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals.The company has 15 manufacturing sites in six countries and marketing presence in 50 countries.The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.

Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab.Arun Kumar is the founder and Group CEO, and has been on the Board as Managing Director since its inception.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs November 2017

20 NOVEMBER
NEWS
19 NOVEMBER
NEWS
18 NOVEMBER
NEWS
17 NOVEMBER
NEWS

Current Affairs October 2017

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Current Affairs September 2017

30 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS
26 SEPTEMBER
NEWS